Stay updated on Alpelisib Plus Fulvestrant in Advanced Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Alpelisib Plus Fulvestrant in Advanced Breast Cancer Clinical Trial page.

Latest updates to the Alpelisib Plus Fulvestrant in Advanced Breast Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedUpdated related topic and resources: 'Multiple endocrine neoplasia' is now listed and the Genetic and Rare Diseases Information Center added. The revision version was updated from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check18 days agoChange DetectedSite revision updated from v3.4.0 to v3.4.1; no visible changes to study details or layout are apparent, To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check32 days agoChange DetectedUI updates include adding a glossary toggle, capitalization adjustments to QC labels, and a new version label (v3.4.0) replacing the previous (v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check39 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3.SummaryDifference0.0%

- Check67 days agoChange DetectedThe Locations section was significantly updated with a large set of new study sites across multiple countries (US states like Arizona, California, Illinois, etc.; Argentina, Australia, EU regions, and more), with deletions removing prior entries.SummaryDifference3%

- Check89 days agoChange DetectedFooter revision label updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Alpelisib Plus Fulvestrant in Advanced Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Alpelisib Plus Fulvestrant in Advanced Breast Cancer Clinical Trial page.